Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Free Report) CEO Christopher U. Missling sold 73,380 shares of the business’s stock in a transaction on Thursday, March 28th. The shares were sold at an average price of $5.11, for a total transaction of $374,971.80. Following the transaction, the chief executive officer now owns 1,250,210 shares in […]
Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Free Report) reached a new 52-week low during trading on Monday . The company traded as low as $6.49 and last traded at $6.51, with a volume of 122815 shares. The stock had previously closed at $6.55. Analysts Set New Price Targets AVXL has been the […]
Barclays PLC increased its position in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Rating) by 1,792.9% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 189,290 shares of the biotechnology company’s stock after acquiring an additional 179,290 shares during the quarter. […]